Invention Grant
- Patent Title: Method for quantitatively determining a therapeutic TNF-alpha inhibitor
-
Application No.: US16962566Application Date: 2019-01-14
-
Publication No.: US11953503B2Publication Date: 2024-04-09
- Inventor: Harald Althaus , Thorsten Keller
- Applicant: Siemens Healthcare Diagnostics Products GmbH
- Applicant Address: DE Marburg
- Assignee: Siemens Healthcare Diagnostics Products GmbH
- Current Assignee: Siemens Healthcare Diagnostics Products GmbH
- Current Assignee Address: DE Marburg
- Agency: BakerHostetler
- Priority: EP 152009 2018.01.17
- International Application: PCT/EP2019/050760 2019.01.14
- International Announcement: WO2019/141614A 2019.07.25
- Date entered country: 2020-07-16
- Main IPC: G01N33/68
- IPC: G01N33/68 ; G01N33/543
Abstract:
Provided is a universal method for quantitatively determining therapeutic tumor necrosis factor (TNF)-alpha inhibitors in patient samples that is sufficiently sensitive for being able to detect all therapeutic TNF-alpha inhibitors.
Information query
IPC分类:
